The prognostic value of preoperative PET/CT evaluation of maximum standardized uptake value in renal cell carcinomas

被引:0
作者
Komek, Halil [1 ]
Altindag, Serdar [1 ]
Can, Canan [1 ]
Aguloglu, Nursin [1 ]
Morcali, Hasan [1 ]
Tuzun, Abidin [2 ]
Kavak, Seyhmus [3 ]
机构
[1] Saglik Bilimleri Univ, Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Nucl Med, Diyarbakir, Turkey
[2] Saglik Bilimleri Univ, Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Gen Surg, Diyarbakir, Turkey
[3] Saglik Bilimleri Univ, Diyarbakir Gazi Yasargil Training & Res Hosp, Dept Radiol, Diyarbakir, Turkey
关键词
FDG; Renal cell Carcinoma; SUVmax; UNKNOWN PRIMARY; CANCER; SURVEILLANCE; TOMOGRAPHY; DIAGNOSIS; NUTRITION; IMPACT; STAGE; MODEL; SIZE;
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Aim: The use of positron emission tomography (PET/CT) in kidney tumors has increased greatly in recent years. There have been few studies on the effect of SUVmax values detected by PET/CT on the mortality and survival estimation in patients with kidney tumors. In this study, it is hoped to contribute to the literature of research on survival and mortality estimations of kidney tumour patients through an evaluation of SUVmax values measured with PET/CT scan. MATERIAL AND METHODS: A retrospective review was made of the files of 21 patients newly-diagnosed with kidney tumor and with disease staging determined with PET/CT in the Nuclear medicine Department of Saglik Bilimleri University Diyarbakir Gazi Yasargil Training and Research Hospital between August 2007 and April 2012. The largest tumor seen on CT was considered as the tumour size and was stated in cm. The survival time was defined as the time from the date of PET/CT Imaging, which was taken into consideration while calculating the survival, and the date of death received from MERNIS (The Central Civil Registration System) or the final application date if the patient was alive. RESULTS: The lower the SUVmax value in the kidney tumour, the longer the survival time. The mortality risk of male patients was 12-fold higher than females and mortality increased 4-fold when SUVmax values were >= 4.5.Patients with a tumour on the right kidney had a longer survival time. With increasedage,survival time decreased. The SUVmax values and tumor size measured in left kidney tumors were higher than those measured in right kidney tumors. CONCLUSIONS: In the present study, it was concluded that the lower the SUVmax values and the smaller the tumour size, the longer the survival time. Mortality rates increased when SUVmax values were >= 4.5 (p=0.001). The use of PET/CT scan can be considered to contribute to mortality and survival estimations in patients with kidney tumor.
引用
收藏
页码:48 / 54
页数:7
相关论文
共 26 条
  • [1] Impact of gender in renal cell carcinoma: An analysis of the SEER database
    Aron, Monish
    Nguyen, Mike M.
    Stein, Robert J.
    Gill, Inderbir S.
    [J]. EUROPEAN UROLOGY, 2008, 54 (01) : 133 - 142
  • [2] Clinical Impact of PET/MR Imaging in Patients with Cancer Undergoing Same-Day PET/CT: Initial Experience in 134 Patients-A Hypothesis-generating Exploratory Study
    Catalano, Onofrio A.
    Rosen, Bruce R.
    Sahani, Dushyant V.
    Hahn, Peter F.
    Guimaraes, Alexander R.
    Vangel, Mark G.
    Nicolai, Emanuele
    Soricelli, Andrea
    Salvatore, Marco
    [J]. RADIOLOGY, 2013, 269 (03) : 857 - 869
  • [3] Characteristics of Primary Papillary Thyroid Carcinoma with False-Negative Findings on Initial 18F-FDG PET/CT
    Choi, Jin Woong
    Yoon, Young Hoon
    Yoon, Yeo Hoon
    Kim, Seong Min
    Koo, Bon Seok
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (05) : 1306 - 1311
  • [4] Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Escudier, B.
    Eisen, T.
    Porta, C.
    Patard, J. J.
    Khoo, V.
    Algaba, F.
    Mulders, P.
    Kataja, V.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 65 - 71
  • [5] Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
    Ferlay, Jacques
    Shin, Hai-Rim
    Bray, Freddie
    Forman, David
    Mathers, Colin
    Parkin, Donald Maxwell
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (12) : 2893 - 2917
  • [6] A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma
    Frank, I
    Blute, ML
    Cheville, JC
    Lohse, CM
    Weaver, AL
    Leibovich, BC
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2003, 170 (06) : 2225 - 2232
  • [7] An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
    Frank, I
    Blute, ML
    Cheville, JC
    Lohse, CM
    Weaver, AL
    Zincke, H
    [J]. JOURNAL OF UROLOGY, 2002, 168 (06) : 2395 - 2400
  • [8] Subtypes of renal cell carcinoma: MRI and pathological features
    Gurel, Safiye
    Narra, Vamsi
    Elsayes, Khaled M.
    Siegel, Cary Lynn
    Chen, Zongming Eric
    Brown, Jeffrey J.
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2013, 19 (04) : 304 - 311
  • [9] Clinical applications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of unknown primary
    Hu Man
    Zhao Wei
    Zhang Pin-liang
    Ju Gui-fang
    Fu Zheng
    Zhang Guo-li
    Kong Li
    Yang Yan-qin
    Ma Yi-dong
    Yu Jin-ming
    [J]. CHINESE MEDICAL JOURNAL, 2011, 124 (07) : 1010 - 1014
  • [10] Renal cell cancer stage migration - Analysis of the National Cancer Data Base
    Kane, Christopher J.
    Mallin, Katherine
    Ritchey, Jamie
    Cooperberg, Matthew R.
    Carroll, Peter R.
    [J]. CANCER, 2008, 113 (01) : 78 - 83